Related references
Note: Only part of the references are listed.Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis
Helga Radner et al.
ARTHRITIS CARE & RESEARCH (2017)
Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy
Francesco Trotta et al.
BMJ OPEN (2017)
Biosimilars in Italy: what do real-world data reveal?
Gianluca Trifiro et al.
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2017)
Infliximab biosimilar CT-P13 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry
P. Gisondi et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Clinical experience with infliximab biosimilar in psoriasis
F. Ricceri et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Patterns of biologic therapy use in the management of psoriasis: cohort study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
I. Y. K. Iskandar et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update
L. Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Patterns of Medication Utilization and Costs Associated with the Use of Etanercept, Adalimumab, and Ustekinumab in the Management of Moderate-to-Severe Psoriasis
Steven R. Feldman et al.
Journal of Managed Care & Specialty Pharmacy (2016)
How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014
Ilaria Marciano et al.
BIODRUGS (2016)
Switching Between Epoetins: A Practice in Support of Biosimilar Use
Carmen D'Amore et al.
BIODRUGS (2016)
Drug survival rates and reasons for drug discontinuation in psoriasis
Tobias Arnold et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2016)
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
Paolo Dapavo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population
Jalpa A. Doshi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
A. Menter et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study
Ylenia Ingrasciotta et al.
PLOS ONE (2016)
How Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013
Ylenia Ingrasciotta et al.
BIODRUGS (2015)
Efficacy comparison of ustekinumab between anti-tumor necrosis factor-α drug-naiive and anti-tumor necrosis factor-α drug-resistant Japanese psoriasis cases
Naomi Takahashi et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Richard B. Warren et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris
R. Gniadecki et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Observational case series on a group of psoriasis patients who failed to respond to any TNF blockers
Manuelle Viguier et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2014)
Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England
Javaria Mona Khalid et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2014)
Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry
Stefano Piaserico et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database
M. Le Moigne et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2014)
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study
Maureen Dubreuil et al.
RHEUMATOLOGY (2014)
Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study
Karen Minde Fagerli et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Treatment Patterns and Health Care Costs for Patients With Psoriatic Arthritis on Biologic Therapy: A Retrospective Cohort Study
Baojin Zhu et al.
CLINICAL THERAPEUTICS (2013)
The Higher Proportion of Men with Psoriasis Treated with Biologics May Be Explained by More Severe Disease in Men
David Hagg et al.
PLOS ONE (2013)
Prevalence and treatment patterns of psoriatic arthritis in the UK
Alexis Ogdie et al.
RHEUMATOLOGY (2013)
Treatment Patterns in the First Year After Initiating Tumor Necrosis Factor Blockers in Real-World Settings
Machaon Bonafede et al.
ADVANCES IN THERAPY (2012)
How Much are Biosimilars Used in Southern Italy? A Retrospective Analysis of Epoetin Utilization in the Local Health Unit of Messina in the Years 2010-2011
Chiara Loiacono et al.
BIODRUGS (2012)
Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis
J. Leman et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Ustekinumab: when everything else fails?
Magalys Vitiello et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Guidelines of care for the management of psoriasis and psoriatic arthritis
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
Daniel H. Solomon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Identification of Risk Factors for Psoriatic Arthritis
Alexis Ogdie et al.
ARCHIVES OF DERMATOLOGY (2010)
Observational case series on a group of patients with severe psoriasis who failed to respond to antitumour necrosis factor α biologics and switched to ustekinumab
A. M. R. Downs
BRITISH JOURNAL OF DERMATOLOGY (2010)
Guidelines of care for the management of psoriasis and psoriatic arthritis Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Guidelines of care for the management of psoriasis and psoriatic arthritis Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Guidelines of care for the management of psoriasis and psoriatic arthritis - Section 2. Psoriatic arthritis: Overview and guidelines of care for treatment with an emphasis on the biologics
Alice Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Regional distribution of psoriasis in Italy
R. Saraceno et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Epidemiology of psoriatic arthritis in the population of the United States
JM Gelfand et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
DD Gladman et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Combination therapy to treat moderate to severe psoriasis
M Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Study design and preliminary results from the pilot phase of the PraKtis study: Self-reported diagnoses of selected skin diseases in a representative sample of the Italian population
L Naldi et al.
DERMATOLOGY (2004)
Share Paper
